Immunovant Inc Q1 2022 Earnings Call Transcript - Thomson StreetEvents

Immunovant Inc Q1 2022 Earnings Call Transcript

Immunovant Inc Q1 2022 Earnings Call Transcript - Thomson StreetEvents
Immunovant Inc Q1 2022 Earnings Call Transcript
Published Aug 09, 2021
11 pages (6998 words) — Published Aug 09, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of IMVT.OQ earnings conference call or presentation 9-Aug-21 12:00pm GMT

  
Brief Excerpt:

...Operator Good morning. My name is Melissa, and I will serve as your conference operator today. (Operator Instructions) As a reminder, this conference is being recorded. Joining me on the call today will be Dr. Pete Salzmann, Chief Executive Officer of Immunovant; and Dr. Frank Torti, Executive Chairperson of Immunovant. Before we begin, I'd like to remind everyone that today's conference will include certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, for example, statements regarding the potential efficacy and safety of Immunovant's product candidate and Immunovant's expectations regarding the timing, design and results of its clinical trials, including the timing of future data readouts and announcement of future indications. These forward-looking statements are not guarantees of future performance and are subject to various risks and uncertainties, assumptions known or unknown, which...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Immunovant Inc
Ticker
IMVT.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Immunovant Inc To Host R&D Day (Virtual) Transcript – 2022-03-30 – US$ 54.00 – Edited Transcript of IMVT.OQ corporate analyst meeting</ 30-Mar-22 1:00pm GMT

Immunovant Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2022-01-13 – US$ 54.00 – Edited Transcript of IMVT.OQ presentation 13-Jan-22 2:45pm GMT

Immunovant Inc To Discuss Initiation of Phase 3 Trial for Batoclimab in Myasthenia Gravis in the First Half of 2022 Call Transcript – 2022-01-05 – US$ 54.00 – Edited Transcript of IMVT.OQ conference call or presentation 5-Jan-22 1:00pm GMT

Immunovant Inc at Stifel Healthcare Conference (Virtual) Transcript – 2021-11-17 – US$ 54.00 – Edited Transcript of IMVT.OQ presentation 17-Nov-21 7:00pm GMT

Immunovant Inc at Roivant R&D Day (Virtual) Transcript – 2021-09-28 – US$ 54.00 – Edited Transcript of IMVT.OQ presentation 28-Sep-21 8:00pm GMT

Immunovant, Inc. - Special Call Transcript – 2021-02-02 – US$ 54.00 – Edited Transcript of IMVT.OQ conference call or presentation 2-Feb-21 1:00pm GMT

Immunovant Inc at Credit Suisse Healthcare Conference (Virtual) Transcript – 2020-11-12 – US$ 54.00 – Edited Transcript of IMVT.OQ presentation 12-Nov-20 3:15pm GMT

Immunovant, Inc. - Special Call Transcript – 2020-08-25 – US$ 54.00 – Edited Transcript of IMVT.OQ conference call or presentation 25-Aug-20 12:30pm GMT

Immunovant Inc Annual Shareholders Meeting Transcript – 2020-08-19 – US$ 54.00 – Edited Transcript of IMVT.OQ shareholder or annual meeting 19-Aug-20 5:00pm GMT

Immunovant Inc Discusses Initial Results From ASCEND GO 1, An Open-Label Phase 2a Trial Of IMVT-1401 In Thyroid Eye Disease, And Provides Corporate Update Transcript – 2020-03-30 – US$ 54.00 – Edited Transcript of IMVT.OQ conference call or presentation 30-Mar-20 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Immunovant Inc Q1 2022 Earnings Call Transcript" Aug 09, 2021. Alacra Store. May 05, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2022-Immunovant-Inc-Earnings-Call-T14949766>
  
APA:
Thomson StreetEvents. (2021). Immunovant Inc Q1 2022 Earnings Call Transcript Aug 09, 2021. New York, NY: Alacra Store. Retrieved May 05, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2022-Immunovant-Inc-Earnings-Call-T14949766>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.